Compass Pathways Begin Period Cash Flow Over Time
| CMPS Stock | USD 3.48 0.01 0.29% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Compass Pathways Performance and Compass Pathways Correlation. Compass |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compass Pathways. If investors know Compass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compass Pathways listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Compass Pathways Plc is measured differently than its book value, which is the value of Compass that is recorded on the company's balance sheet. Investors also form their own opinion of Compass Pathways' value that differs from its market value or its book value, called intrinsic value, which is Compass Pathways' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compass Pathways' market value can be influenced by many factors that don't directly affect Compass Pathways' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compass Pathways' value and its price as these two are different measures arrived at by different means. Investors typically determine if Compass Pathways is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compass Pathways' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Begin Period Cash Flow Analysis
Compare Compass Pathways Plc and related stocks such as InnovAge Holding Corp, agilon health, and US Physicalrapy Begin Period Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INNV | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 61.2 M | 114.6 M | 203.7 M | 184.4 M | 127.3 M | 146.4 M | 136 M |
| AGL | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 145.6 M | 139.1 M | 1.1 B | 507.7 M | 114.3 M | 108.6 M |
| USPH | 1.9 M | 9.2 M | 10 M | 11.7 M | 12.9 M | 14.3 M | 15.8 M | 20 M | 21.9 M | 23.4 M | 23.5 M | 32.9 M | 28.6 M | 31.6 M | 152.8 M | 160.5 M |
| EHAB | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 34.8 M | 40 M | 8 M | 27.2 M | 29.8 M | 21.7 M |
| ENSG | 14.8 M | 72.1 M | 29.6 M | 40.7 M | 65.8 M | 50.4 M | 41.6 M | 57.7 M | 42.3 M | 31.1 M | 59.2 M | 236.6 M | 262.2 M | 316.3 M | 509.6 M | 535.1 M |
| CCRN | 4.8 M | 11 M | 10.6 M | 10.5 M | 8.1 M | 5 M | 2.5 M | 20.6 M | 25.5 M | 16 M | 1 M | 1.6 M | 1 M | 3.6 M | 17.1 M | 10.6 M |
| AMED | 1.1 M | 120.3 M | 48 M | 14.5 M | 17.3 M | 8 M | 27.5 M | 30.2 M | 86.4 M | 20.2 M | 96.5 M | 83.4 M | 45.8 M | 54.1 M | 138.9 M | 145.8 M |
| ACHC | 4.5 M | 8.6 M | 61.1 M | 49.4 M | 4.6 M | 94 M | 11.2 M | 57.1 M | 67.3 M | 50.5 M | 124.2 M | 378.7 M | 133.8 M | 97.6 M | 100.1 M | 91.1 M |
| ADUS | 3 K | 816 K | 2 M | 1.7 M | 15.6 M | 13.4 M | 4.1 M | 8 M | 53.8 M | 70.4 M | 111.7 M | 145.1 M | 168.9 M | 80 M | 64.8 M | 45.6 M |
| SGRY | 5.4 M | 5.4 M | 5.4 M | 5.2 M | 13 M | 74.9 M | 57.9 M | 57.9 M | 175.2 M | 184.6 M | 93 M | 318.2 M | 389.9 M | 282.9 M | 195.9 M | 156.9 M |
| PNTG | 27 K | 27 K | 27 K | 27 K | 27 K | 27 K | 27 K | 30 K | 36 K | 41 K | 402 K | 43 K | 5.2 M | 2.1 M | 6.1 M | 6.4 M |
| NHC | 6.4 M | 28.5 M | 61 M | 66.7 M | 81.7 M | 69.8 M | 49.3 M | 31.6 M | 67.4 M | 54.9 M | 61 M | 158.5 M | 119.7 M | 74.9 M | 126 M | 132.3 M |
| DVA | 1.4 M | 860.1 M | 393.8 M | 533.7 M | 946.2 M | 965.2 M | 1.5 B | 674.8 M | 518.9 M | 415.4 M | 1.2 B | 501.8 M | 555 M | 339 M | 464.6 M | 450.7 M |
Compass Pathways Plc and related stocks such as InnovAge Holding Corp, agilon health, and US Physicalrapy Begin Period Cash Flow description
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.My Equities
My Current Equities and Potential Positions
| Compass Pathways Plc | CMPS |
Specialization | Health Care, Health Care Equipment & Services |
| Location | United Kingdom |
| Exchange | NASDAQ Exchange |
USD 3.48
Additional Tools for Compass Stock Analysis
When running Compass Pathways' price analysis, check to measure Compass Pathways' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Pathways is operating at the current time. Most of Compass Pathways' value examination focuses on studying past and present price action to predict the probability of Compass Pathways' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Pathways' price. Additionally, you may evaluate how the addition of Compass Pathways to your portfolios can decrease your overall portfolio volatility.